Page
%P
-
Article
Low-Dose Losartan Therapy Reduces Proteinuria in Normotensive Patients with Immunoglobulin A Nephropathy
The present study was designed to assess the antiproteinuric effects of a low dose of an angiotensin II–receptor blocker, losartan, in normotensive patients with immunoglobulin A (IgA) nephropathy. We performe...